跳至主要内容
临床试验/NCT01985204
NCT01985204已完成不适用

Assessment of the Improvement of the Cardiovascular Risk Profile in Obese Women After Correction of Iodine Deficiency

Swiss Federal Institute of Technology2 个研究点 分布在 1 个国家目标入组 162 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
162
试验地点
2
主要终点
change in fasting insulin

研究概览

简要总结

The study hypothesis is that iodine supplementation will lower serum TSH and leptin concentrations and thereby improve the lipid and glucose profile.

详细描述

The study will be a double blind, placebo controlled intervention study in obese women living in the Atlas foot mountains in Morocco, an iodine deficient area. Eligible subjects will be randomized into intervention and control group and will receive the respective supplement for 6 months. At baseline, midpoint and endpoint anthropometric as well as metabolic profile will be assessed. A health questionnaire will further be administered monthly when the tablets for the following month are distributed. Urine samples to determine iodine status will also be collected monthly.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women of reproductive age (20 to 50 years)
  • Body mass index 27 to 40 kg/m2
  • Having received oral and written information about the aims and procedures of the study
  • Willing to comply with the study procedure
  • Having provided oral and written informed consent

排除标准

  • Chronic disease or gastrointestinal disorders
  • Nodular goiter
  • Regular use of medication (except oral contraceptives)
  • Pregnancy or lactation
  • Subject who cannot be expected to comply with study protocol

结局指标

主要结局

change in fasting insulin

时间窗: change from baseline to 6 months

change in the LDL cholesterol/ HDL cholesterol ratio

时间窗: change from baseline to 6 months

Change in TSH (thyroid-stimulating hormone)

时间窗: change from baseline to 6 months

次要结局

  • fasting glucose(baseline, 3 months and 6 months)
  • LDL cholesterol(baseline, 3 months and 6 months)
  • HDL cholesterol(baseline, 3 months and 6 months)
  • Urinary iodine(change from baseline to 6 months)
  • plasma leptin(baseline, 3 months and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Isabelle Aeberli

PhD

Swiss Federal Institute of Technology

研究点 (2)

Loading locations...

相似试验